Planet Labs PBC (PL) Financial Statements
Planet Labs PBC (PL) reported trailing twelve-month revenue of $378.3M (up 44.1% year on year) and net income of -$359.9M as of 2026-07-31, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $19.9M.
Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason
PLPlanet Labs PBCFollow PL — free
—
Price chart with a free account
- Market cap
- 4.9B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 8 Dec, in 45 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jul 26.
| Line | FY2022 Jan 22 | FY2023 Jan 23 | FY2024 Jan 24 | FY2025 Jan 25 | FY2026 Jan 26 | TTM Jul 26 | Trend |
|---|---|---|---|---|---|---|---|
| Revenue | 0.13 | 0.19 | 0.22 | 0.24 | 0.31 | 0.38 | |
| Gross profit | 0.05 | 0.09 | 0.11 | 0.14 | 0.17 | 0.21 | |
| Research & development | 0.07 | 0.11 | 0.12 | 0.10 | 0.11 | 0.13 | |
| Operating income | -0.13 | -0.18 | -0.17 | -0.12 | -0.10 | -0.10 | |
| Pre-tax income | -0.14 | -0.16 | -0.14 | -0.12 | -0.24 | -0.35 | |
| Income tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net income | -0.14 | -0.16 | -0.14 | -0.12 | -0.25 | -0.36 | |
| Diluted EPS ($) | -1.72 | -0.61 | -0.50 | -0.42 | -0.80 | -1.00 | |
| Diluted shares (bn) | 0.080 | 0.267 | 0.280 | 0.292 | 0.308 | — |
USD billions · SEC XBRL
Planet Labs PBC — questions
- What is Planet Labs PBC's revenue?
- $378.3M over the twelve months to 2026-07-31, up 44.1% year on year, from its 10-Q and 10-K filings.
- What is Planet Labs PBC's net income?
- -$359.9M over the twelve months to 2026-07-31.
- What is Planet Labs PBC's free cash flow?
- $19.9M over the twelve months to 2026-07-31.
- What are Planet Labs PBC's diluted earnings per share?
- $-1.00 over the twelve months to 2026-07-31.
Every figure on this page comes from Planet Labs PBC's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.